Nurix Therapeutics NRIX
NASDAQ NRIX
$23.67 +0.00 (+0.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Operating Expenses (2019 - 2026)

Updated

Nurix Therapeutics' Operating Expenses came in at $103.25 million for fiscal Q2 2026 (quarter ended May 31, 2026), up 11.8% from $92.38 million a year earlier and up 4.6% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Operating Expenses (2019 - 2026) Analysis & Trends

Over the trailing twelve months to May 31, 2026, Nurix Therapeutics reported Operating Expenses of $397.95 million, up 24.8% year-over-year; for FY2025 (ended Nov 30, 2025), it came in at $369.65 million, up 38.1% from FY2024.

  • Operating Expenses has increased in each of the last six fiscal years, with a five-year compound annual growth rate of 34.9% (FY2020 to FY2025).
  • Going back by fiscal year, Operating Expenses was $267.58 million in FY2024 (+15.3%), $232.05 million in FY2023 (+4.3%), $222.49 million in FY2022 (+50.7%) and $147.64 million in FY2021 (+78.3%).
  • The fiscal Q2 2026 figure represents the highest quarterly Operating Expenses in data going back to fiscal Q3 2019.
  • Year-over-year, Operating Expenses has increased for 24 consecutive quarters, with growth averaging 29.1% over the last eight quarters.
  • The year-over-year growth in Operating Expenses has ranged between 0.5% (fiscal Q2 2023) and 77.3% (fiscal Q1 2022) over the last five years.
  • Business Quant data shows NRIX's Operating Expenses at $98.75 million (Q1 2026), $96.67 million (Q4 2025) and $99.28 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - 103.25 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 103.25 Mn
Feb 28, 2026 98.75 Mn
Nov 30, 2025 96.67 Mn
Aug 31, 2025 99.28 Mn
May 31, 2025 92.38 Mn
Feb 28, 2025 81.32 Mn
Nov 30, 2024 77.94 Mn
Aug 31, 2024 67.20 Mn
May 31, 2024 60.63 Mn
Feb 29, 2024 61.80 Mn
Nov 30, 2023 60.49 Mn
Aug 31, 2023 58.48 Mn
May 31, 2023 57.44 Mn
Feb 28, 2023 55.64 Mn
Nov 30, 2022 55.47 Mn
Aug 31, 2022 57.51 Mn
May 31, 2022 57.15 Mn
Feb 28, 2022 52.37 Mn
Nov 30, 2021 45.35 Mn
Aug 31, 2021 39.25 Mn
API Access

Nurix Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NRIX&period=max&api_key=YOUR_API_KEY